AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together, "AusperBio"), a biopharmaceutical company developing oligonucleotide therapeutics, today announced long-term follow-up data from ...
Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet medical ...
QurAlis reported interim ANQUR trial results showing target engagement, a biomarker signal, and a trend toward slower ...
(Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo ...
FDA alignment on pivotal Phase 3 study design and CMC strategy marks an important milestone in VG801’s clinical developmentVG801 demonstrates consistent and sustained functional improvements through ...
FDA alignment on pivotal Phase 3 study design and CMC strategy marks an important milestone in VG801’s clinical developmentVG801 demonstrates consistent and sustained functional improvements through M ...
All ELEVATE-44-201 Cohort 1 participants have completed open-label dosing, with data expected to be received by year-end 2026 -- ...
Kiloamp busbars, high-voltage solar, compact robots and nanoamp budgets are reshaping magnetic sensor selection. Read More.
The Association of Science Laboratory Technologists of Nigeria (ASLTON) has called on the Federal Government to establish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results